Recombinant CD52 (Alemtuzumab Biosimilar) 抗体
This anti-CD52 (Alemtuzumab Biosimilar) antibody is a 小鼠 单克隆 antibody detecting CD52 (Alemtuzumab Biosimilar) in FACS 和 in vivo. Suitable for 人.
Quick Overview for Recombinant CD52 (Alemtuzumab Biosimilar) 抗体 (ABIN7795101)
抗原
CD52 (Alemtuzumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
小鼠
克隆类型
单克隆
标记
This CD52 (Alemtuzumab Biosimilar) antibody is un-conjugated
应用范围
Flow Cytometry (FACS), In vivo Studies (in vivo)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Alemtuzumab Biosimilar, Human CD52 Monoclonal Antibody
-
产品特性
- Alemtuzumab Biosimilar uses the same protein sequences as the therapeutic antibody alemtuzumab. Alemtuzumab is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis. In CLL, it has been used as both a first line and second line treatment. In MS it is generally only recommended if other treatments have not worked. It is given by injection into a vein. It is a monoclonal antibody that binds to CD52, a protein present on the surface of mature lymphocytes, but not on the stem cells from which these lymphocytes are derived. After treatment with alemtuzumab, these CD52-bearing lymphocytes are targeted for destruction.
-
纯化方法
- Protein A or G affinity column
-
纯度
- >95 % by reducing SDS-PAGE
-
内毒素水平
- < 1 EU per 1 mg of the protein by the LAL method
-
免疫原
- Human CD52
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- > 3 mg/mL
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- CD52 (Alemtuzumab Biosimilar)
-
别名
- Alemtuzumab Biosimilar
-
物质类
- Biosimilar
抗原
-
You are here:
